Indication
Evrenzo is indicated for treatment of adult patients with symptomatic anaemia associated with chronic kidney disease (CKD).
In other countries
The same active substances on other registers, the same brand first.
National listings
The national registers that list this EU medicine.
- Evrenzo 100 MG Comprimidos Recubiertos con PeliculaSpain · 100 mgMarketed
- Evrenzo 150 MG Comprimidos Recubiertos con PeliculaSpain · 150 mgMarketed
- Evrenzo 20 MG Comprimidos Recubiertos con PeliculaSpain · 20 mgMarketed
- Evrenzo 50 MG Comprimidos Recubiertos con PeliculaSpain · 50 mgMarketed
- Evrenzo 70 MG Comprimidos Recubiertos con PeliculaSpain · 70 mg